OTC Markets OTCQX - Delayed Quote USD

Cannara Biotech Inc. (LOVFF)

1.4500 0.0000 (0.00%)

As of November 3 at 4:00:00 PM EST. Market Open.

Cannara Expands International Supply Agreement with Curaleaf

GlobeNewswire 30d ago

LOVE.TO

CURA.TO

LOVFF
0.00%
Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth

GlobeNewswire 1mo ago

LOVE.TO

BMO

8CB0.F
Cannara Appoints Nicholas Fozard as Chief Financial Officer

GlobeNewswire 2mo ago

LOVFF
0.00%
8CB0.F

LOVE
Cannara Establishes Automatic Share Purchase Plan

GlobeNewswire 2mo ago

LOVFF
0.00%
8CB0.F

LOVE
Cannara Announces Normal Course Issuer Bid

GlobeNewswire 3mo ago

LOVE.TO

LOVFF
0.00%
8CB0.F
Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion

GlobeNewswire 3mo ago

LOVFF
0.00%
LOVE.NE

LOVE.TO
Cannara Announces a Long-Term International Cannabis Supply Agreement with Curaleaf International Limited

GlobeNewswire 3mo ago

8CB0.F

LOVE

LOVFF
0.00%
Cannara to Announce Fiscal Q3 2026 Financial Results on July 15, 2026

GlobeNewswire 3mo ago

LOVE.TO

LOVFF
0.00%
LOVE.NE
Cannara Secures Exclusive Canadian Rights to Blue River's Ampersand™ Live Rosin Infusion Technology

GlobeNewswire 4mo ago

LOVE.TO

8CB0.F

LOVE.NE
Cannara Completes Acquisition of Medican Organic Inc.

GlobeNewswire 5mo ago

LOVE.TO

8CB0.F

LOVE.NE
Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec

GlobeNewswire 6mo ago

LOVE.TO

LOVE

LOVFF
0.00%
Why Is Curaleaf Holdings (TSX:CURA) Expanding Its International Supply Deal?

Simply Wall St. 27d ago

CURA.TO

LOVE.TO

U.S. markets close in 44m

Cannara Biotech Inc. (LOVFF)

Cannara Expands International Supply Agreement with Curaleaf

Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth

Cannara Appoints Nicholas Fozard as Chief Financial Officer

Cannara Establishes Automatic Share Purchase Plan

Cannara Announces Normal Course Issuer Bid

Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion

Cannara Announces a Long-Term International Cannabis Supply Agreement with Curaleaf International Limited

Cannara to Announce Fiscal Q3 2026 Financial Results on July 15, 2026

Cannara Secures Exclusive Canadian Rights to Blue River's Ampersand™ Live Rosin Infusion Technology

Cannara Completes Acquisition of Medican Organic Inc.

Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec

Why Is Curaleaf Holdings (TSX:CURA) Expanding Its International Supply Deal?